Risk reducing strategies in women with family history

Recent article in JCO suggesting benefit with strategies such as tamoxifen in ‘at risk women’ such as a moderate family history. This follows an article from Kelly-Anne Phillips at Peter Mac ¬†showing the benefit ¬†of Tamoxifen in BRCA carriers.